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ABSTRACT: Aldehyde oxidase (AO) is a molybdenum-
containing enzyme involved in the clearance of drug
compounds containing aldehydes and N-containing hetero-
cyclic fragments. AO has gained considerable interest in recent
years because of examples of too fast clearance of drug
compounds in development. Thus, it is important to be able to
predict AO-mediated drug metabolism. Therefore, we have
characterized the structural and energetic aspects of diﬀerent
mechanisms with density functional theory using the
molybdenum cofactor as a model for the reactive part of the
enzyme. For a series of 6-substituted 4-quinazolinones, the trend in activation energies is the same for three tested reaction
mechanisms. Using the concerted mechanism as a model for the enzymatic reaction, the transition states (TSs) for the formation
of all possible metabolites for a series of known AO substrates were determined. The lowest activation energies correspond in all
cases to the experimentally observed sites of metabolism (SOMs). Various molecular properties were calculated and investigated
as more easily determinable markers for reactivity. The stabilities of both intermediates and products correlate to some extent
with the TS energies and may be used to predict the SOM. The electrostatic-potential-derived charges are also good markers for
the prediction of the experimental SOM for this set of compounds and may pave the way for the development of fast methods
for the prediction of SOM for AO substrates.
■ INTRODUCTION
Aldehyde oxidase (AO) is an enzyme located in the cytosol of
cells and belongs to the xanthine oxidase (XO) family of
molybdoenzymes that requires a molybdenum cofactor
(MoCo) for the catalytic activity.1,2 The precise physiological
role of AO remains unclear, but in humans, it plays an
important role in drug metabolism.2,3 Although aldehydes are
not often present in drug compounds, this functional group can
be a result of biotransformation by other drug metabolizing
enzymes, such as the cytochrome P450s, and can be
subsequently oxidized to a carboxylic acid by AO. More
importantly in drug discovery, AO oxidizes a range of N-
containing heterocyclic aromatic rings that are often present in
drug compounds. Therefore, several drug discovery projects
have been discontinued after clinical evaluation owing to high
clearance.2 However, AO activity can also be exploited to
activate compounds, increasing the bioavailability as observed
for famciclovir. In addition to the broad substrate proﬁle of AO,
it can also reduce N- and S-oxides and hydrolyze amides.4
In drug discovery projects, it is important to understand and
predict the AO-mediated reactions of new compounds,
preferably prior to synthesis. In several theoretical studies,
diﬀerent reaction mechanisms have been investigated and it
may be diﬃcult to prove which is correct. These types of
investigations are typically done with density functional theory
(DFT) on a model system containing a part of the MoCo and
the substrate. For AO and XO, Alfaro and Jones suggest a
concerted mechanism, in that the transition state (TS) has the
OH of MoCo attacking the sp2-hybridized C atom while the H
atom of the substrate is transferred to the S atom of the MoCo
because it explains the trends in the rate of product formation
for a series of 4-substituted quinazolinones and also the large
observed deuterium isotope eﬀects.5 The eﬀect of a
neighboring Glu residue, Glu1270 in human AO, on the
activation energies has been estimated to enhance the stability
of the TS and thus decrease the activation energy for the
reaction.5,6 Other mechanisms for the related XO have been
proposed in which an O instead of OH attacks the C atom of
the substrate and where a proton is transferred to the
neighboring O of aldehydes or N of xanthine. The next step,
the hydride transfer to S of MoCo, is the rate-limiting step.7−9
The mechanistic studies have primarily been done with DFT,
and the TSs are typically time-consuming to determine.
Therefore, other simpler methods to estimate the most
probable site of metabolism (SOM) have been applied to
larger sets of compounds. For example, Torres et al.
investigated the partial charges on the aromatic C atom and
the stability of the hydroxylated intermediates and found that
the latter energy descriptor provided a good predictor for
reaction by AO.10 Models combining the stabilities of the
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intermediates with a steric factor have been developed to
address whether the SOM is accessible to predict clearance and
formation of SOMs.11,12 Xu et al.12 used these two descriptors
to develop a decision-tree model for the prediction of SOM
with predictivity values of 0.905 and 0.867 for the training and
test set, respectively. This model predicts either the most
reactive sites or medium reactive sites that are accessible as
SOMs. The decision-tree model was shown to be more
predictive than a model that is only based on the intermediate.
In this work, we use MoCo to study the AO reactions by
DFT calculations to determine the activation energies for the
possible reactions. Thus, the steric restraints from the enzyme
are not included, which is a potential pitfall for using the
activation energies for the prediction of SOMs. However, it has
previously been observed that the electronic features of
substrates play a major role in the prediction of AO
metabolites.10 Several reaction mechanisms have been consid-
ered, and their reaction proﬁles were determined. Finally, we
relate other molecular properties characterizing the reaction
with the activation energies to enable fast estimates of AO
oxidations on large sets of compounds.
■ RESULTS AND DISCUSSION
Mechanism for 6-Substituted 4-Quinazolinones. The
6-substituted 4-quinazolinone compounds are both XO and AO
substrates. Initially, activation energies were determined for the
same series of 6-substituted 4-quinazolinone compounds as
studied by Alfaro and Jones (see Figure 1).5 We studied both
the concerted and stepwise mechanisms, as these previously
have been proposed as plausible reaction mechanisms. In
addition, the eﬀect of deprotonation of the Mo-bound OH was
investigated to mimic the transfer of a proton to the nearby
Glu1270 residue. The diﬀerent mechanisms are shown in
Figure 1. Reaction mechanisms of 6-substituted 4-quinazolinones (R = NO2, CF3, Cl, H, CH3, OCH3, and NH2) studied in this work. (A) Reaction
1: concerted mechanism, (B) reaction 2: concerted mechanism with deprotonated MoCo, and (C) reaction 3: stepwise mechanism with an initial
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Figure 1. All energies and distances are shown in Supporting
Information, Tables S1−S3.
For the concerted mechanism (Figure 1A, reaction 1), the
MoCo-bound OH makes a nucleophilic attack on the C atom
(C2) next to the N atom while the H atom is transferred to the
S atom of MoCo. The structures of the reactants, TSs, and
products along with the energies are plotted in Figure 2A. As
observed previously,5 4-quinazolinone compounds with elec-
tron-withdrawing substituents at position 6 have the lowest
activation energies while the electron-donating substituents
increase the barriers (see Table 1). In vacuum, the B3LYP-
calculated activation energies range from 164 to 181 kJ/mol by
comparing the TS and reactant energies, whereas the activation
energies are 93−141 kJ/mol (cf. Table S1A) when compared
with the separated MoCo and substrate species. Notably, the
trends are exactly the same whether the reactants or separated
species are used as reference (R2 = 0.98). These energies are
high but on average agree within 1 kJ/mol with previously
determined energies for the same substrates when comparing
the TS to the separated MoCo and substrate species. With
B3LYP-D3, that is, including dispersion, the activation energies
are similar (within ∼8 kJ/mol) to those determined with
B3LYP and the trends are the same as also observed by the
correlation to the B3LYP energies (R2 = 0.99). The reactions
are characterized by short OMoCo−CSub distances (∼1.5 Å) and
rather long HSub−Csub distances (∼1.4 Å) in the TS (cf. Table
S1A). In agreement with the observations by Alfaro and Jones,
the lower activation barriers for the electron-withdrawing
groups result in slightly shorter OMoCo−CSub and longer HSub−
Csub distances, which is more similar to the product structures.
5
Near MoCo, there is a Glu residue, Glu1270 in human AO,
which has been considered to be able to deprotonate the OH of
MoCo in XO and AO.5,13 Initially, we included a model for this
residue in the calculations to mimic the activation or the
deprotonation of the OH group. However, we did not succeed
in optimizing the TS. We then characterized the reaction with a
deprotonated OH in MoCo (Figures 1B and 2A, reaction 2).
By doing this, the possible energetic penalty for deprotonating
OH is ignored. This signiﬁcantly decreases the activation
energies to 35−93 and 32−89 kJ/mol for B3LYP and B3LYP-
D3, respectively (see Table 1), and a correlation of R2 = 0.98
with the concerted mechanism with an OH in MoCo is
observed (Figure 1A, reaction 1). Including solvation increases
these barriers because the MoCo with a formal charge of −2 is
stabilized in the presence of solvent. For example, the activation
barrier for 4-quinazolinone increases from 84 kJ/mol in vacuum
to 110 and 123 kJ/mol for ε = 4 and 80, respectively (see
Supporting Information, Table S2).
Both of these mechanisms involve a concerted oxidation of
the substrate and a hydride transfer from the substrate to
MoCo, a mechanism already suggested in 1987 by Skibo et al.14
Figure 2. Reaction proﬁles for (A) reaction 1 (red lines) and 2 (black
lines) and (B) reaction 3 for 4-quinazolinone.
Table 1. TS Energies (kJ/mol) for Reactions 1−3 Described in Figure 1a,b
B3LYP B3LYP-D3
reaction 1 2 3 3 1 2 3 3
substituent R TS TS TS1 TS2 TS TS TS1 TS2
NO2 163.6 35.1 71.0 48.8 156.8 31.7 66.9 47.3
CF3 170.0 56.9 77.0 56.6 163.2 53.4 71.0 54.5
Cl 175.2 73.7 79.2 61.1 167.5 69.7 72.3 58.8
H 175.8 83.6 79.7 61.2 166.8 79.0 72.6 58.7
CH3 178.1 85.9 79.9 63.0 169.6 81.7 72.4 60.6
OCH3 178.7 88.9 81.8 66.9 170.9 85.0 75.5 64.5
NH2 181.1 93.0 84.3 69.8 172.2 89.1 76.3 67.2
R2c 0.98 0.96 0.97 0.99 0.98 0.90 0.96
aAll TS energies are determined in vacuum with B3LYP or B3LYP-D3. The energies are given relative to the reactant complex. bEnergies for the
separated MoCo and substrate, the intermediates, and the products are given in Tables S1−S3. cCorrelation to the activation energy for reaction 1 at
the B3LYP level. The correlation with the activation energy for reaction 1 determined as the energy diﬀerence between the TS and the sum of the
separated MoCo and substrate is R2 = 0.98. The correlation between TS1 and TS2 for reaction 3 is 0.98 at both B3LYP and B3LYP-D3 levels.
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based on kinetic studies on substituted quinazolinones by
buttermilk XO and in agreement with more recent computa-
tional studies.5
Next, we studied the hydrogen transfer of the MoCo-bound
OH to the N atom of the substrate, followed by the formation
of a tetrahedral intermediate and a subsequent H transfer to the
S atom of MoCo (Figure S1A, reaction 4).6−8,15 However,
instead we observed that the other O atom bound to MoCo
spontaneously reacted with the aromatic atom as shown in
Figures 1C and 2B (reaction 3). The activation energies for the
initial proton transfer are rate-limiting and range from 71 to 84
kJ/mol in vacuum and are systematically smaller with B3LYP-
D3 by about 4−8 kJ/mol. The subsequent transfer of the H
atom to the S atom of MoCo has a lower TS energy, and the
trends in barrier height are similar to the ﬁrst and rate-limiting
step.
Because the TS along the path presented in Figure S1A could
not be identiﬁed, it was then tested if the trends from a
previous study about oxidation of xanthine could be
reproduced.7 In this study, MoCo oxidizes a negatively charged
xanthine (Figure S1B, reaction 4) because previous QM/MM
studies had shown this to be a favorable reaction path. Despite
diﬀerences in the methods (e.g., inclusion of relativistic eﬀects
and dispersion functional), we could reproduce trends from
these TS energies (see Table S4), that is, the nucleophilic attack
on the carbonyl C atom is lower in energy than the subsequent
H transfer to the S atom of MoCo. Further examination of the
binding pocket of AO (PDB entries 4UHW and 4UHX)16
reveals, however, that there is not a residue to abstract the
proton from the substrates, like Glu802 in XO, and therefore,
we did not pursue this reaction further.
Although the diﬀerent reaction mechanisms studied with this
small model system have very diﬀerent activation energies in
absolute numbers, the relative trends of the rate-limiting TS
energies are the same with R2 of 0.98 and 0.96 for reactions 2
and 3 at the B3LYP level compared with reaction 1 (Table 1).
Figure 3. AO substrates. Atom numbering according to Moss.17 DACA was represented by 4-methyl-acridine. Famciclovir was modeled as 2-
aminopurine. */** indicate primary/secondary SOMs. Aromatic C atoms were colored according to TS energies (kJ/mol, at the B3LYP level) for
the concerted reaction. TS energies are relative to the separated MoCo and substrate (cf. Tables S6−S11). The scale is from 131.9 kJ/mol (C4 of
quinazoline) to 203.9 kJ/mol (C4 of phenanthridine). Nonaromatic C atoms and aromatic N atoms are colored white.
Figure 4. DFT-calculated transition energies (B3LYP-level ZPE-corrected BS2 energies) for the AO substrates. For each compound, the TS energies
for the aromatic C atoms are listed. */** indicate primary/secondary SOMs.
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Thus, all mechanisms are equally useful for the following
studies because the ranking of the TS energies at diﬀerent sites
in a substrate would be the same. We decided to continue with
the concerted mechanism because it agrees well with the
observed large deuterium isotope eﬀects, suggesting that the
hydride transfer to the S atom of MoCo is rate-limiting.14
Moreover, reaction 3 would require a heteroatom accepting a
proton as neighbor to the C atom that is oxidized, which is not
always the case, for example, for a substrate such as N-[2-
(dimethylamino)ethyl]acridine-4-carboxamide (DACA). Thus,
in the following, the TSs were determined with the mechanism
for reaction 1.
Activation Energies for AO Substrates. To explore the
reactions for AO substrates, we investigated all possible AO
sites in quinazoline, phthalazine, and quinoline using reaction 1
(Figure 3). For comparison, the most electron-withdrawing
(NO2) or electron-donating (NH2) substituents at position 6 of
quinazoline were included. Moreover, the observed AO SOMs
of phenanthridine and DACA were included. The latter,
DACA, was included because it has an unusual SOM opposite
to the N atom of the aromatic ring. Finally, we also studied
famciclovir as an example of a compound, where AO
metabolism increases the bioavailability of the active species.
Quinazolines. The trends in activation energies for
oxidations of C2 in 6-NO2 and 6-NH2 quinazolines were
similar to the 6-substituted 4-quinazolidine compounds, that is,
the electron-withdrawing group has a low barrier (Table S5).
Considering all possible aromatic C atoms for quinazoline, C2
and C4, that is, the observed AO SOMs, have the lowest
barriers of 154.2 and 131.9 kJ/mol, respectively (cf. Table S6,
TS energies at the B3LYP level relative to separated MoCo and
substrate). The primary SOM, C4, has the lowest barrier as
clearly seen in Figure 4, where it is also observed that positions
5, 6, 7, and 8 have signiﬁcantly higher TS energies of 164.9−
191.1 kJ/mol.
Phthalazine. Phthalazine has three diﬀerent C atoms, which
in principle can be oxidized by AO. The reaction with the
lowest TS energy of 152.1 kJ/mol oxidizes C4 and yields 1-
phthalazinone (Figure 4 and Table S7), which also is the
primary metabolite observed experimentally.18 Reactions on C5
and C6 have higher TS energies of 184.1 and 188.6 kJ/mol,
respectively.
Quinoline. Although quinoline itself is not a drug
compound, the quinoline moiety is present in numerous drug
compounds and natural products.19 Examples on quinoline-
containing compounds are the alkaloids such as quinine,
quinidine, cinchonine, and cinchonidine, which all are oxidized
at C2 in the quinoline moiety to give the corresponding
lactams.20 The DFT calculations show that oxidation at the
most reactive C atom C2 has a TS energy of 156.2 kJ/mol
(Figure 4 and Table S8) and corresponds to the experimentally
observed AO metabolite of quinoline.21 TS energies for
reactions on the remaining C atoms range from 167.1 to
202.4 kJ/mol.
Famciclovir. Famciclovir is a prodrug of penciclovir with an
improved oral bioavailability. The conversion of famciclovir to
penciclovir requires hydrolyses of the ester functionalities and
an AO-mediated oxidation of the 2-aminopurine moiety at
position 6 forming the 6-oxo-metabolite. In addition to this
major metabolite, the isomeric 8-oxo- and the 6,8-dioxo-
metabolites are also formed in smaller amounts.22 The TS
energy for forming the 8-oxo-metabolite of 151.9 kJ/mol is 20
kJ/mol (Figure 4 and Table S9), lower than that required for
the formation of the 6-oxo-metabolite (with the primary
SOM); however, both reactions have relatively low TS energies.
Thus, the TS energies do not reﬂect the formation of the
primary and secondary metabolites, which are most likely due
to the steric hindrance at C8, an eﬀect that is not taken into
account when not considering the rest of the enzyme. It is also
worth mentioning that the DFT calculations were not done on
the actual famciclovir molecule, but on the parent moiety, 2-
amino-9-methylpurine, that is, without considering the ﬂexible
substituent on N9.
N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide.
DACA has been included in this study because it is a substrate
for AO, although it does not contain a cyclic −CHN−
moiety. Experimentally, it has been shown that metabolism
takes place at position 9, yielding the 9(10H)-acridone
metabolite.23 The DFT calculations were performed on 4-
methylacridine and showed that oxidation at C9 has the lowest
TS energy of 153.7 kJ/mol (Figure 4 and Table S10), whereas
the other C oxidations are in the range of 170.0−190.0 kJ/mol
and, thus, more unfavorable. Although not having a
neighboring N atom, the geometry in the TS for oxidation of
C9 is very similar to those on C atoms in substrates next to a N
atom (comparing Tables S9 with S1−S8, S11). Other
metabolic enzymes may also metabolize DACA, CYP450 may
give N-demethylated metabolites and FMO may give N-oxide,
and these metabolites may subsequently be oxidized at C9 by
AO.24 The result for this atypical AO substrate suggests that the
mechanism-based approach presented here is not limited to
−CHN− containing compounds but is generally applicable.
This is in contrast to reaction 3 in which the H atom of the Mo-
bound OH is transferred to a N atom next to the C atom of the
substrate.
Phenanthridine. In phenanthridine, C6 is the most reactive
site, and oxidation proceeds via the lowest TS energy (150.7
kJ/mol, cf. Table S11) in agreement with experimental data
showing that phenanthridinone is the only metabolite formed
by AO.25 This energy is signiﬁcantly lower than that of TS
energies of 171.3−203.9 kJ/mol for the other C atoms.
Considering the DFT-calculated TS energies for all of the
relevant C atoms, the TS energies at the B3LYP level for the
experimentally observed SOMs range from 131.9 (C4 of
quinazoline) to 172.0 kJ/mol (C6 of famciclovir). For
quinazoline, phthalazine, quinoline, DACA, and phenanthri-
dine, the lowest TS energies are observed for the atoms that are
the experimentally observed primary SOMs. For famciclovir,
both of the experimentally observed primary and secondary
SOMs correspond to atoms associated with low TS energies.
Thus, based on these AO substrates, it seems that a threshold
of ∼160 kJ/mol could be used to estimate whether AO
oxidation takes place.
The present approach considers only the interactions
between the MoCo and the substrate and, accordingly, ignores
the eﬀect of the surrounding protein. The substrate speciﬁcity
between AO and XO metabolisms seems to be caused by two
residues in the active site: Val811 and Met889 in AO and
Glu802 and Arg880 in XO.26 Thus, the active site in AO is
more hydrophobic than the XO active site, where the Glu802
and Arg880 residues in several X-ray structures are seen to ﬁx
the orientation of the substrate by several hydrogen bonds.27
One may therefore speculate that AO-mediated metabolism
primarily is determined by reactivity and XO-mediated
metabolism by reactivity and the possibility for establishing
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some speciﬁc hydrogen bonds. In both cases, the shape of the
active sites may also play a role.
Fast Methods for the Prediction of SOM. Because the
TS energies are time-consuming to determine, we investigated
if other estimates of the reactivity could be used to indicate
whether a site in the AO substrate is a likely SOM. The
energies of the species formed along the reaction pathway were
determined, that is, stability of the hydroxylated tetrahedral
intermediate, the cation intermediate, and the product (Figure
S2 and Table S12). We also considered the electronic
properties of the aromatic C atoms via their electrostatic
potential (ESP) and natural bond order (NBO) charges (Table
S12). All calculated estimates of the intermediate or product
stability were correlated with the TS energies. The best
correlations are observed for the stability of the products and
the ESP charges with R2 of 0.62 and 0.58, respectively. Slightly
worse correlations are observed for the intermediate stabilities
and NBO charges (cf. Table 2 and Figure S3). As shown in
Figures 5 and S4, the stabilities of the intermediate, the cation,
and the product are generally more favorable for the SOMs
than the non-SOMs, whereas positively charged C atoms are
characteristic for the atoms being SOMs.
More important than the correlation coeﬃcient is the ability
to distinguish between SOMs and non-SOMs. As already
noted, the TS energies are lowest for the SOMs, and thus, they
could be good predictors of where the AO reaction oxidizes the
substrates. This is also clearly observed in the box plots in
Figure 5 where the box and whiskers for the SOMs are in a
narrow range of ∼150 kJ/mol with only two outliers (C4 of
quinazoline and C6 of famciclovir, see also Figure 4). The
product stabilities and ESP or NBO charges of the SOMs are
separated from the other aromatic C atoms in Figure 5. Thus,
for larger sets of compounds, it would be reasonable to
consider these simpler properties as indicators of AO-mediated
SOM than determining the more time-consuming TS energies.
Torres et al.10 investigated the relationship between the
charge of a carbon atom near a nitrogen atom and the ability to
predict the SOM in the compound. Their conclusion was that
ESP charges were not as predictive as other reactivity measures
because they were not always able to predict the primary SOM
correctly. Although the ESP (and NBO) charges do not
correlate well with the activation energy of the diﬀerent sites,
the most positive charges are the SOMs in all compounds,
except for DACA. In DACA, C3 has a charge that is +0.13
compared with +0.11 for C9 (cf. Table S12C). Torres et al.
instead used the stability of the tetrahedral intermediate, with
OH added to the C atom and an H atom added to the N atom,
resulting in a net addition of water, to predict >90% of the
SOMs correctly. The stability of the intermediate was also used
as a descriptor by Jones and Korzekwa and Xu et al.11,12 As
seen in Figure 5, there is a separation between the SOM and
the non-SOM stability for our estimates of the tetrahedral
intermediates. Two sites are not correctly predicted (the
intermediate generated from a reaction on C4 of quinoline and














TS energies 0.52 0.15 0.62 0.58 0.47
stability of
intermediates









aThe TS energies are given relative to the energies of separated
substrate and MoCo at the B3LYP level.
Figure 5. Box plot of calculated properties for the reaction. Red bars show the values for the SOMs and blue for the other aromatic C atoms.
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C7 of phenanthridine is more stable). The energy of the
intermediate for C9 of DACA, on the other hand, is very low
(214 kJ/mol compared with all other intermediates). Although
the decision-tree model is an ultrafast method, the determi-
nation of the energy diﬀerence at the B3LYP level reduces the
speed of the method and it could be interesting to develop a
model based on the ESP charges, where only one calculation is
necessary, instead of a calculation of both the substrate and the
intermediate.
■ CONCLUSIONS
We have studied three diﬀerent mechanisms for the AO-
mediated oxidation of N-containing heterocyclic compounds
and their trend in activation energies. We showed that the TS
energies for all three reactions correlate. In addition, B3LYP
and B3LYP-D3 energies correlate. For one of the mechanisms,
the concerted mechanism, we have determined the activation
energy for the formation of all possible metabolites showing
that the reaction with the lowest activation barrier generally
corresponds to the formation of the experimentally observed
metabolite.
We have also shown that the SOM for AO-mediated
metabolism can be derived from various molecular properties
such as the ESP partial charges, which indicates that it will be
possible to develop methods to predict SOM, which are
considerably faster than the methods relying on identifying TSs.
■ METHODS
The MoCo was modeled as a Mo−dithiolene complex, with an
oxygen, a hydroxyl, and a sulfur substituent. All calculations
were done at the DFT/B3LYP or DFT/B3LYP-D3 level of
theory.28−31 Previous calculations on reactions with Mo-
containing model systems with 1,2-dimethyldithiolene bound
have shown that B3LYP can reproduce coupled cluster-derived
energies.32,33 The TSs were identiﬁed by scanning the reaction
coordinates before the TS optimizations were done. The TSs
were veriﬁed by making a frequency calculation. All structures
were optimized using the def2-SVP basis set, and the ﬁnal
energies were determined using the def2-larger TZVPP basis
set.34 The energies were corrected for the zero-point vibrations.
It is indicated that the energies are corrected for solvation with
the COSMO model with dielectric constants of 4 and 80.35 The
COSMO calculations were done with optimized radii of H, C,
N, O, and S and 2.0 Å for Mo.7 All activation energies were
given relative to the sum of the MoCo and substrate energies.
ESP and NBO charges were calculated for each atom of the
diﬀerent substrates with single-point DFT calculations, using
the def2-SVP basis set. For the stability of intermediates, cation
and product geometry optimizations were conducted using the
def2-SVP basis set.34 As shown in Figure S2, the diﬀerence in
energy was calculated between the substrate and MoCo and (1)
the sum of the product and the protonated and dehydroxylated
MoCo; (2) the sum of the intermediate and the dehydroxylated
MoCo; and (3) the sum of the cation and the MoCo + H−.
TURBOMOLE was used for all DFT calculations.36
■ ASSOCIATED CONTENT
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mammalian aldehyde oxidase crystal structure: insights into substrate
specificity. J. Biol. Chem. 2012, 287, 40690−40702.
(14) Skibo, E. B.; Gilchrist, J. H.; Lee, C. H. Electronic probes of the
mechanism of substrate oxidation by buttermilk xanthine oxidase: role




ACS Omega 2017, 2, 4237−4244
4243
(15) Metz, S.; Wang, D.; Thiel, W. Reductive half-reaction of
aldehyde oxidoreductase toward acetaldehyde: a combined QM/MM
study. J. Am. Chem. Soc. 2009, 131, 4628−4640.
(16) Coelho, C.; Foti, A.; Hartmann, T.; Santos-Silva, T.;
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